A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection

NCT05047601 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

2954

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: PF-07321332
DRUG: Placebo for PF-07321332
DRUG: Placebo for Ritonavir
DRUG: Ritonavir

Sponsor

Pfizer